Vensica is developing ViXe, a product that combines Xeomin, a commercial neurotoxin, and Vibe, a breakthrough, needle-free, ultrasound drug delivery device.Vibe is a breakthrough platform designed to deliver drugs directly into the bladder wall, providing uniform, controlled and localized treatments for urology applications.Vibe leverages a disruptive ultrasound technology to deliver drugs through the natural barriers of the urinary bladder.

By generating cavitation bubbles, Vibe precisely microinjects the drugs into the bladder wall, ensuring a controlled and uniform delivery of medications and biologics.